BrainStorm Cell Therapeutics
BCLI
#10103
Rank
โ‚ฌ6.39 M
Marketcap
0,98ย โ‚ฌ
Share price
14.87%
Change (1 day)
-87.04%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of December 2024 : โ‚ฌ0.63 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is โ‚ฌ0.63 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚ฌ3.81 M-14.92%
2021-12-31โ‚ฌ4.48 M-23.57%
2020-12-31โ‚ฌ5.86 M177.81%
2019-12-31โ‚ฌ2.11 M
2018-12-31N/A
2010-12-31โ‚ฌ0.1 M-60.12%
2009-12-31โ‚ฌ0.25 M-18.5%
2008-12-31โ‚ฌ0.31 M-69.98%
2007-12-31โ‚ฌ1.05 M23.68%
2006-12-31โ‚ฌ0.85 M
2006-03-31โ‚ฌ0.4 M
2004-03-31โ‚ฌ0.02 M29.85%
2003-03-31โ‚ฌ0.01 M67.17%
2002-03-31โ‚ฌ0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ23.37 B 3,709,761.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.69 B 109,438.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ99.32 M 15,662.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ5.80 B 920,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.03 M 13,076.39%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA